These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1835541)

  • 1. Nicotinamide and the hypoxia problem.
    Horsman MR
    Radiother Oncol; 1991 Oct; 22(2):79-80. PubMed ID: 1835541
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
    Brown JM; Wouters BG
    Radiat Res; 1997 Nov; 148(5):526-7. PubMed ID: 9355876
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
    Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
    Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
    [No Abstract]   [Full Text] [Related]  

  • 4. ARCON: accelerated radiotherapy with carbogen and nicotinamide.
    Rojas A
    BJR Suppl; 1992; 24():174-8. PubMed ID: 1290695
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioprotectors: current status and new directions.
    Grdina DJ; Murley JS; Kataoka Y; Zhou D; Seed TM
    Radiat Res; 2005 Jun; 163(6):704-5. PubMed ID: 16044505
    [No Abstract]   [Full Text] [Related]  

  • 6. SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells.
    Xie Y; Zhang J; Xu Y; Shao C
    J Radiat Res; 2012; 53(1):44-50. PubMed ID: 22302044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosanoids and radiation.
    Milas L; Hanson WR
    Eur J Cancer; 1995 Sep; 31A(10):1580-5. PubMed ID: 7488405
    [No Abstract]   [Full Text] [Related]  

  • 8. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
    Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
    Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of nicotinamide and carbogen on the radiation tolerance of the spinal cord of the rat].
    Raabe A
    Strahlenther Onkol; 1994 Nov; 170(11):674-5. PubMed ID: 7974185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of radiation injuries during multifractionation in radiation therapy].
    Zholkiver KI; Zevrieva IF
    Med Radiol (Mosk); 1983 Apr; 28(4):3-6. PubMed ID: 6835069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor dose-time-volume.
    Cancer; 1976 Apr; 37(4 Suppl):2056-61. PubMed ID: 1260702
    [No Abstract]   [Full Text] [Related]  

  • 12. [The determination of the optimal irradiation dose in the tumor tissue-normal body tissues system].
    Klepper LIa
    Med Tekh; 1997; (4):18-21. PubMed ID: 9379858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARCON.
    Rojas A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():34-5. PubMed ID: 8946047
    [No Abstract]   [Full Text] [Related]  

  • 14. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
    Hartmann KA; Van der Kleij AJ; Schneider CJ; Sminia P
    Radiat Res; 1997 Nov; 148(5):523-5. PubMed ID: 9355875
    [No Abstract]   [Full Text] [Related]  

  • 15. Finding our sensitive patients.
    Buchholz TA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):547-8. PubMed ID: 10524402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methodic approaches using normobaric interval hypoxia and impulse magnetic field to increase nonspecific and anti-radio resistance in workers of ecologically unfavorable industries].
    Ushakov IB; Izmerov NF; Bukhtiiarov IV; Dvornikov MV; Stepanov VK; Usov VM; Lobkaeva EP; Nikitina LS; Sudarev AM; Valyeva IuV; Labyntseva IuM
    Med Tr Prom Ekol; 2005; (2):11-5. PubMed ID: 15822341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Approximate methods for calculation of the likelihood of radiation complications. The generalized PKLQ method (GPKLQM)].
    Klepper LIa
    Med Tekh; 2002; (5):27-32. PubMed ID: 12512280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbogen and nicotinamide: expectations too high?
    Brown JM
    Radiother Oncol; 1992 Jun; 24(2):75-6. PubMed ID: 1386679
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy.
    Anscher MS; Chen L; Rabbani Z; Kang S; Larrier N; Huang H; Samulski TV; Dewhirst MW; Brizel DM; Folz RJ; Vujaskovic Z
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):255-9. PubMed ID: 15850930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.
    Rojas A; Joiner MC; Denekamp J
    Radiother Oncol; 1992 Jun; 24(2):123-4. PubMed ID: 1386678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.